Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
LLY compared with ESPR: revenue, margins and what each company keeps, and the suppliers and customers both name
LLY
ELI Lilly & Co
Change
Mkt cap
Revenue
Revenue
ESPR
Esperion Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
LLY
ELI Lilly & Co
vs
ESPR
Esperion Therapeutics, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Supply-chain overlap
Desk
News
Calendar
Saved
Search
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only LLY
29
MCK
McKesson
customer
CAH
Cardinal Health
customer
VEEV
Veeva Systems
supplier
UTHR
United Therapeutics
customer
25 more · LLY chain
›
Shared
0
No shared counterparties.
Only ESPR
7
PFE
Pfizer
supplier
—
Neopharm
unlisted
customer
—
Otsuka Pharmaceutical
unlisted
customer
—
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
Seqirus Pty Ltd (CSL Seqirus)
unlisted
customer
3 more · ESPR chain
›
LLY
ELI Lilly & Co
Change
1,363.96
▼
−0.06%
Mkt cap
$1.2T
Revenue
$24.4B
Q3 FY26
Revenue
$65.2B
FY25
ESPR
Esperion Therapeutics, Inc.
Change
3.20
▲
+0.31%
Regular session
Nov 6 '26
Mkt cap
$818.6M
Revenue
$80M
Q1 FY26
Revenue
$403M
FY25
vs
Compare
Regular session
Nov 6 '26
LLY
ELI Lilly & Co
vs
ESPR
Esperion Therapeutics, Inc.
1,363.96
▼
−0.06%
Price
3.20
▲
+0.31%
$1.2T
Mkt cap
$818.6M
Q3 FY26
$24.4B
Revenue
$80M
Q1 FY26
FY25
$65.2B
Revenue
$403M
FY25
Change
Change
LLY
1,363.96
▼
−0.06%
vs
ESPR
3.20
▲
+0.31%
Regular session
Nov 6 '26